The present invention features MCH antagonists active at the MCH-1R. The antagonists are optionally modified peptides able to inhibit the effect of MCH at MCH-1R. MCH antagonists have a variety of uses including being used as a research tool and being used to achieve a beneficial effect in a subject.

 
Web www.patentalert.com

< Methods for treating inflammatory conditions or inhibiting JNK

> Production of oligosaccharides in transgenic plants

~ 00414